News
SNU-3173
His : 1791
Name : 관리자
2021-04-27 13:22:43
Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutations.,
J Thorac Oncol. 2019 Sep;14(9):1556-1566.
total : 3(now : 1/total pages : 1)
| Subject | Date | Hit | |
|---|---|---|---|
| 3 | SNU-2535, EML4-ALK positive lung cancer cell lin | 2021-04-27 | 2470 |
| 2 | SNU-3173 | 2021-04-27 | 1792 |
| 1 | new English website | 2021-04-27 | 1695 |
‹ Prev 1
- Cell Line
- Search for cell lines
- Order cell lines
- Restriction on use
- Papers using SNU series
- Cell Line STR profile
- Cancer Cell Line Panel
- Cell Culture Cluster
- Central Bank of Cell Culture Cluster
- Deposit of Bio-Resources
- Deposit of Bio-Resources
- Patent Deposit
- Patent Deposit
- Patent deposit information
- General Deposit
- Safety Deposit
- Application for deposit
- STR,QC&Service
- DNA fingerprinting analysis
- Species verification test
- Mycoplasma detection test
- Viral detection test
- Microsatellite instability analysis
- DNA extraction service
- cDNA synthesis service
- Pellet service
- Anticancer drug screening service
- Cell stock manufacture in GMP facility
- Customized service
- Hands-on Workshops
- Collection of Animal Cell Line
- About Us
- KCLB
- Message from the Director
- Contact Us
- News
Korean Cell Line Bank, Korean Cell Line Research Foundation,
101, Daehak-ro, Jongno-gu, Seoul, 03080, Korea
대표자 : 박재갑 | Personal Information Security Officer : 신영경 | Company Registration Number : 208-82-03887
Tel : 82-2-3668-7915 | Fax : 82-2-742-0021 | Email : kclb@kclb.kr
KCLB (C) is a registered mark of Korean Cell Line Bank. All rights reserved. 1998~2015